Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)

NCT04197453 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT04197453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04197453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
Lead sponsor
Amgen
Phase
Observational
Overall status
Terminated
Start date
December 6, 2019
Completion date
December 21, 2020
Enrollment
752 (actual)
Sites
164

Conditions

As the registry lists them; a condition with its own page is linked.

ascvd